VI Spanish Consensus Conference on the treatment of Helicobacter pylori infection.

Authors

Javier P Gisbert, Javier Alcedo, Javier Amador, Jesús Barrio, Luis Bujanda, Xavier Calvet, Luis Fernández-Salazar, José María Huguet, Ángel Lanas, Alfredo J Lucendo, Samuel J Martínez-Domínguez, Leticia Moreira, Olga P Nyssen, Pablo Parra, Ángeles Pérez-Aisa, Javier Tejedor-Tejada

Published in

Gastroenterologia y hepatologia. Pages 502847. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

Helicobacter pylori (H. pylori) infection is highly prevalent in the Spanish population and is the main cause of chronic gastritis, peptic ulcer disease, and gastric cancer. Five previous consensus meetings on the management of H. pylori infection in Spain have been held, the most recent in 2021. Changes in treatment regimens and the growing body of available evidence justified the organization of this VI Spanish Consensus Conference in June 2026, focused on the treatment of this infection. Sixteen experts in the field participated, performed a systematic literature search, and developed 25 recommendations, which were subsequently submitted to an iterative process of serial anonymous voting using Delphi methodology. The GRADE system was used to classify the certainty of the evidence and the strength of the recommendations. As a starting point, this consensus establishes that the recommended treatments should achieve, and preferably exceed, a 90% cure rate when administered empirically. Accordingly, quadruple regimens are recommended as both first-line and rescue treatments. As first-line treatment, a 10-day regimen with a proton pump inhibitor plus bismuth, tetracycline, and metronidazole (Pylera®) is recommended. After failure of this regimen, a combination of a proton pump inhibitor, amoxicillin, levofloxacin, and bismuth is recommended. This consensus also provides a detailed review of other rescue treatment alternatives.

PMID:
42816313
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.